^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    IL20RB overexpression

    i
    Other names: IL20RB, Interleukin 20 Receptor Subunit Beta, Fibronectin Type III Domain Containing 6, IL-20R2, DIRS1, Interleukin 20 Receptor Beta Subunit, Interleukin-20 Receptor Subunit Beta, IL-20 Receptor Subunit Beta, IL-20R-Beta, IL-20RB, FNDC6, Interleukin 20 Receptor Beta, Interleukin-20 Receptor II, MGC34923, IL20RB
    Entrez ID:
    53833
    2years
    IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer. (PubMed, J Transl Med)
    Our findings demonstrate that IL20RB plays a crucial role in promoting stemness in pancreatic cancer. This discovery provides a potential therapeutic target for this lethal disease.
    Journal
    |
    IL20RB (Interleukin 20 Receptor Subunit Beta)
    |
    IL20RB overexpression